Gilead Wins Appeals Court Ruling Blocking Imported HIV Drug Sales
On August 13, a federal appeals court ruled in favor of Gilead Sciences, Inc.
Posts Tagged ‘NASDAQ:GILD’
Bixlenvo Gives Gilead a New HIV Growth Path. How Large is the Market?
Gilead Sciences, Inc.
Gilead’s Core Business Is Accelerating, But Will Its $11 Billion Pipeline Bet Pay Off?
Gilead Sciences, Inc. (NASDAQ:GILD) produced an unusual earnings report in fiscal Q2 2026.
Gilead’s HIV Business is Surging, but is the Company Too Dependent on One Franchise?
Gilead Sciences, Inc. (NASDAQ:GILD) delivered strong fiscal Q2 2026 results, with total revenue rising 10% year over year to approximately $7.8 billion.
Gilead’s Revenue Is Accelerating, But are its Acquisitions Worth the Cost?
Gilead Sciences, Inc.
Pfizer vs. Gilead: Which Drugmaker Has the Stronger Growth Story?
The next few years will test whether Pfizer Inc. (NYSE:PFE) can replace yesterday’s blockbusters, and whether Gilead Sciences, Inc.
Can MacroGenics (MGNX) Turn Gilead Sciences (GILD)’s $10M Milestone Into a Major Pipeline Catalyst?
On August 11, Gilead Sciences, Inc. (NASDAQ:GILD) exercised its option to exclusively license a preclinical bispecific program targeting solid tumors using MacroGenics, Inc.
Could Merck & Co., Inc. (MRK) and Gilead Sciences, Inc. (GILD)’s Partnership Create the Next Big Pharma Growth Engine
Two biopharma giants, Merck & Co., Inc. (NYSE:MRK) and Gilead Sciences, Inc.
Could Gilead Sciences (GILD) Have a Major HIV Growth Engine in Yeztugo?
Baron Capital, an investment management company, released its Q2 2026 investor letter for the “Baron Health Care Fund”. A copy of the letter is available to download here.
12 Most Profitable Cheap Stocks to Buy Right Now
In this article, we will be taking a look at the 12 Most Profitable Cheap Stocks to Buy Right Now.
10 Most Undervalued NASDAQ Stocks to Buy Right Now
In this article, we will discuss the 10 Most Undervalued NASDAQ Stocks to Buy Right Now.
12 Most Profitable S&P 500 Stocks to Invest In
In this article, we will look at the 12 Most Profitable S&P 500 Stocks to Invest In.
10 Set-It-and-Forget-It Stocks to Buy Right Now
In this article, we will take a look at the 10 Set-It-and-Forget-It Stocks to Buy Right Now.
7 Best Longevity and Anti-Aging Stocks to Buy
In this article, we will discuss 7 Best Longevity and Anti-Aging Stocks to Buy.
10 Undervalued Counter Cyclical Stocks to Buy Now
In this article, we will look at the 10 Undervalued Counter Cyclical Stocks to Buy Now.
Top 10 Income Stocks with the Highest Upside Potential
In this article, we will take a look at the Top 10 Income Stocks with the Highest Upside Potential. Growth is often the primary objective of an investment strategy.
10 Most Undervalued Quality Stocks to Invest In
In this article, we will discuss the 10 Most Undervalued Quality Stocks to Invest In.
7 Best Longevity Stocks to Buy Now
In this article, we will look at the 7 Best Longevity Stocks to Buy Now.
Top 10 Large Cap Value Stocks to Buy Now
In this article, we will discuss the Top 10 Large Cap Value Stocks to Buy Now.
10 Deep Value Stocks to Invest In Now
In this article, we will discuss the 10 Deep Value Stocks to Invest In Now.
Is Gilead Sciences, Inc. (GILD) A Good Stock To Buy Now?
Is GILD a good stock to buy? We came across a bullish thesis on Gilead Sciences, Inc. on r/investing_discussion by Variant_Invest.
8 Best Quality Growth Stocks to Buy
In this article, we will discuss the 8 Best Quality Growth Stocks to Buy.
Gilead Sciences (GILD) Announces New Results From a Post Hoc Analysis
Gilead Sciences, Inc. (NASDAQ:GILD) is one of the best inexpensive stocks to invest in right now. Gilead Sciences, Inc.
Gilead Sciences, Inc. (GILD) Gains Attention as Livdelzi Demonstrates Long-Term Efficacy and Safety
We recently compiled a list of the 11 Most Undervalued Pharma Stocks to Invest In. Gilead Sciences, Inc. (NASDAQ:GILD) is one of the most undervalued stocks to invest in.
9 Best Inexpensive Stocks to Invest In Right Now
In this article, we will look at the 9 Best Inexpensive Stocks to Invest In Right Now.
10 Safest Dividend Stocks to Buy Right Now
In this article, we will take a look at the 10 Safest Dividend Stocks to Buy Right Now.
11 Most Undervalued Pharma Stocks to Invest In
In this article, we will be taking a look at the 11 Most Undervalued Pharma Stocks to Invest In.
12 Most Profitable Stocks to Invest In
In this article, we will look at the 12 Most Profitable Stocks to Invest In.
10 Cheap NASDAQ Stocks to Buy Right Now
In this article, we will discuss the 10 Cheap NASDAQ Stocks to Buy Right Now.
12 Best Dividend Stocks to Invest In According to Hedge Funds
In this article, we are going to discuss the 12 best dividend stocks to invest in according to hedge funds.
14 Best Extremely Profitable Stocks to Buy According to Wall Street Analysts
In this piece, we will discuss the 14 Best Extremely Profitable Stocks to Buy According to Wall Street Analysts.
10 Best Long Term Low Risk Stocks to Buy According to Hedge Funds
In this article, we will take a look at the 10 Best Long Term Low Risk Stocks to Buy According to Hedge Funds.
Gilead Sciences, Inc. (GILD) Outlook Cut Sharply on $11.5B IPR&D and Financing Costs
We recently compiled a list of the 10 Best Cancer Stocks to Buy for the Long Term. Gilead Sciences, Inc. is among the best cancer stocks to invest in.
10 Best Cancer Stocks to Buy for the Long Term
In this article, we will be taking a look at the 10 Best Cancer Stocks to Buy for the Long Term.
Gilead Sciences, Inc. (NASDAQ:GILD) Q1 2026 Earnings Call Transcript
Gilead Sciences, Inc. (NASDAQ:GILD) Q1 2026 Earnings Call Transcript May 7, 2026Gilead Sciences, Inc. beats earnings expectations.
Is Gilead Sciences, Inc. (GILD) A Good Stock To Buy Now?
Is GILD a good stock to buy? We came across a bullish thesis on Gilead Sciences, Inc. on Trevor Young’s Substack.
Gilead Sciences (GILD) Set to Acquire Arcellx
Gilead Sciences, Inc. (NASDAQ:GILD) is one of the best stem cell therapy stocks to buy. Gilead Sciences, Inc.
8 Best Stem Cell Therapy Stocks to Buy
In this article, we will look at the 8 Best Stem Cell Therapy Stocks to Buy.
14 Best Defensive Stocks to Invest In Now
In this article, we discuss the Best Defensive Stocks to Invest In Now.
Morgan Stanley Adjusts Gilead Sciences, Inc. (GILD) Outlook Ahead of Q1 Earnings
We recently compiled a list of the 10 Best Healthcare Stocks to Buy and Hold for 3 Years. Gilead Sciences, Inc. is one of the best healthcare stocks.
Jim Cramer’s 11 Stocks Review: HOOD, WFC, and Market Rotation
In this article, we will look at the stocks Jim Cramer reviewed on Mad Money while discussing the recent market rotation.
10 Best Healthcare Stocks to Buy and Hold for 3 Years
In this article, we will be taking a look at the 10 Best Healthcare Stocks to Buy and Hold for 3 Years.
10 Healthcare Stocks with Highest Dividends
In this article, we will take a look at the 10 Healthcare Stocks with Highest Dividends.
13 NASDAQ Stocks with Highest Dividends
In this article, we will take a look at the 13 NASDAQ Stocks with Highest Dividends.
8 Best Quality Stocks to Buy According to Hedge Funds
In this article, we will discuss the 8 Best Quality Stocks to Buy According to Hedge Funds.
7 Most Profitable Value Stocks to Buy Right Now
In this article, we will discuss the 7 Most Profitable Value Stocks to Buy Right Now.
15 Best Low Volatility Blue Chip Stocks to Buy Now
In this article, we will take a look at the 15 Best Low Volatility Blue Chip Stocks to Buy Now. The S&P 500 has declined by over 3.5% in 2026 so far.
Dividend Stock Portfolio for Income: 15 Stocks to Invest In
In this article, we will take a look at the Dividend Stock Portfolio for Income: 15 Stocks to Invest In. Growth often takes center stage in an investing strategy.
Gilead Sciences, Inc. (GILD): Growth Prospects Backed by Analyst Upgrades
Gilead Sciences Inc. (NASDAQ:GILD) is one of Goldman Sachs top healthcare stocks. On March 10, Jefferies initiated coverage of Gilead Sciences Inc.
Goldman Sachs Healthcare Stocks: Top 10 Stock Picks
In this article, we will discuss the Goldman Sachs Healthcare Stocks: Top 10 Stock Picks.
Hedge Fund Resource Center
